Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119554) titled 'A Phase IIa trial of Androtriol Injection for the Treatment of Intracerebral Hemorrhage: a Multicenter, Randomized, Double-blind, Placebo-controlled Study' on Feb. 28.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Xiangya Hospital of Central South University
Condition:
Intracerebral Hemorrhage
Intervention:
Experimental group1:Androtriol Injection, 30 mL per time (5 mL per ampoule, i.e., 6 ampoules per time), intravenous drip, every 12 hours, drip completed in 30 minutes, administered continuously for 7 days
Experimental group2:Androtriol Injection 10ml, Hydroxypropyl Beta-Cycl...